Updated guidelines from the American Academy of Neurology recommend plasma exchange (plasmapheresis) for the treatment of certain types of multiple sclerosis (MS) and other inflammatory neurological conditions, including Guillain-Barré syndrome and CIDP (chronic inflammatory demyelinating polyneuropathy).

Click here to read the full story.

No profanity or inappropriate comments will be allowed.
Offensive posters will be blocked from future postings.